Simone Schadt

1.1k total citations
28 papers, 751 citations indexed

About

Simone Schadt is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Simone Schadt has authored 28 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Oncology. Recurrent topics in Simone Schadt's work include Metabolomics and Mass Spectrometry Studies (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and DNA and Nucleic Acid Chemistry (4 papers). Simone Schadt is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and DNA and Nucleic Acid Chemistry (4 papers). Simone Schadt collaborates with scholars based in Switzerland, Germany and United States. Simone Schadt's co-authors include Carsten Hopf, Michael Becker, Sandra Schulz, M. Reid Groseclose, Roderich D. Süßmuth, Simone Keller, Andreas Brink, Christoph Funk, Christophe Husser and M. Zell and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Analytical Chemistry.

In The Last Decade

Simone Schadt

28 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Schadt Switzerland 14 395 231 122 122 98 28 751
Sérgio Luiz Dalmora Brazil 16 263 0.7× 190 0.8× 160 1.3× 72 0.6× 83 0.8× 81 817
Sumiko Hyuga Japan 17 564 1.4× 149 0.6× 227 1.9× 156 1.3× 166 1.7× 54 982
Alexander V. Veselovsky Russia 18 662 1.7× 101 0.4× 88 0.7× 136 1.1× 154 1.6× 90 1.1k
Masashi Hyuga Japan 17 519 1.3× 113 0.5× 221 1.8× 154 1.3× 124 1.3× 48 950
Aaron T. Wecksler United States 22 550 1.4× 183 0.8× 150 1.2× 62 0.5× 260 2.7× 35 1.2k
Diya Lv China 19 474 1.2× 98 0.4× 103 0.8× 197 1.6× 39 0.4× 47 905
Patrick J. Rudewicz United States 18 371 0.9× 296 1.3× 65 0.5× 68 0.6× 96 1.0× 39 822
Thomas N. O’Connell United States 12 367 0.9× 82 0.4× 141 1.2× 129 1.1× 125 1.3× 19 698
Kaifeng Hu China 19 820 2.1× 186 0.8× 57 0.5× 26 0.2× 50 0.5× 84 1.2k
Dieter M. Drexler United States 17 675 1.7× 439 1.9× 127 1.0× 122 1.0× 68 0.7× 50 1.2k

Countries citing papers authored by Simone Schadt

Since Specialization
Citations

This map shows the geographic impact of Simone Schadt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Schadt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Schadt more than expected).

Fields of papers citing papers by Simone Schadt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Schadt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Schadt. The network helps show where Simone Schadt may publish in the future.

Co-authorship network of co-authors of Simone Schadt

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Schadt. A scholar is included among the top collaborators of Simone Schadt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Schadt. Simone Schadt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Bin, Upendra A. Argikar, Luying Chen, et al.. (2025). Metabolism of new drug modalities research advances – 2024 year in review. Drug Metabolism Reviews. 57(4). 467–504. 1 indexed citations
2.
Ma, Bin, Upendra A. Argikar, Lionel Cheruzel, et al.. (2024). Metabolism of new drug modalities research advances – 2023 year in review. Drug Metabolism Reviews. 56(3). 223–246. 2 indexed citations
3.
Wang, Shuai, T. Eric Ballard, Lisa J. Christopher, et al.. (2023). The Importance of Tracking “Missing” Metabolites: How and Why?. Journal of Medicinal Chemistry. 66(23). 15586–15612. 11 indexed citations
4.
Duschmalé, Jörg, Erik Daa Funder, Steffen Schmidt, et al.. (2022). Investigating discovery strategies and pharmacological properties of stereodefined phosphorodithioate LNA gapmers. Molecular Therapy — Nucleic Acids. 29. 176–188. 5 indexed citations
5.
Zeller, Andreas, Alessandro Brigo, Andreas Brink, et al.. (2019). Genotoxicity Assessment of Drug Metabolites in the Context of MIST and Beyond. Chemical Research in Toxicology. 33(1). 10–19. 9 indexed citations
6.
Husser, Christophe, et al.. (2019). Studying the Biotransformation of Phosphorothioate-Containing Oligonucleotide Drugs by LC-MS. Methods in molecular biology. 2036. 307–315. 4 indexed citations
7.
Schadt, Simone, Simon Hauri, Roland F. Staack, et al.. (2019). Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical Challenges. Drug Metabolism and Disposition. 47(12). 1443–1456. 32 indexed citations
8.
Schadt, Simone, Bojan Bister, Swapan K. Chowdhury, et al.. (2018). A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development under the “Metabolites in Safety Testing” Regulatory Guidance. Drug Metabolism and Disposition. 46(6). 865–878. 78 indexed citations
9.
Husser, Christophe, Axel Pähler, Mark Seymour, et al.. (2018). Profiling of dalcetrapib metabolites in human plasma by accelerator mass spectrometry and investigation of the free phenothiol by derivatisation with methylacrylate. Journal of Pharmaceutical and Biomedical Analysis. 152. 143–154. 8 indexed citations
10.
Schulz, Sandra, Michael Becker, M. Reid Groseclose, Simone Schadt, & Carsten Hopf. (2018). Advanced MALDI mass spectrometry imaging in pharmaceutical research and drug development. Current Opinion in Biotechnology. 55. 51–59. 231 indexed citations
11.
Lenz, Barbara, Andreas Brink, Anne De Paepe, et al.. (2017). Application of Imaging Techniques to Cases of Drug-Induced Crystal Nephropathy in Preclinical Studies. Toxicological Sciences. 163(2). 409–419. 12 indexed citations
12.
Brink, Andreas, Axel Pähler, Christoph Funk, Franz Schuler, & Simone Schadt. (2016). Minimizing the risk of chemically reactive metabolite formation of new drug candidates: implications for preclinical drug design. Drug Discovery Today. 22(5). 751–756. 30 indexed citations
13.
Zell, M., Christophe Husser, Roland F. Staack, et al.. (2016). In Vivo Biotransformation of the Fusion Protein Tetranectin-Apolipoprotein A1 Analyzed by Ligand-Binding Mass Spectrometry Combined with Quantitation by ELISA. Analytical Chemistry. 88(23). 11670–11677. 15 indexed citations
16.
Jones, Russell G., Michael Keller, Na Qiu, et al.. (2015). Shedding light on minipig drug metabolism – elevated amide hydrolysisin vitro. Xenobiotica. 46(6). 483–494. 4 indexed citations
17.
Zhong, Sheng, Russell G. Jones, Wenzhe Lu, Simone Schadt, & Giorgio Ottaviani. (2015). A New Rapid In Vitro Assay for Assessing Reactivity of Acyl Glucuronides. Drug Metabolism and Disposition. 43(11). 1711–1717. 19 indexed citations
18.
Schadt, Simone, et al.. (2011). Investigation of Figopitant and Its Metabolites in Rat Tissue by Combining Whole-Body Autoradiography with Liquid Extraction Surface Analysis Mass Spectrometry. Drug Metabolism and Disposition. 40(3). 419–425. 31 indexed citations
19.
Schadt, Simone, Agnes Mühlenweg, Stefan Pelzer, et al.. (2011). Abyssomicin Biosynthesis: Formation of an Unusual Polyketide, Antibiotic‐Feeding Studies and Genetic Analysis. ChemBioChem. 12(9). 1401–1410. 60 indexed citations
20.
Keller, Simone, et al.. (2007). Action of atrop‐Abyssomicin C as an Inhibitor of 4‐Amino‐4‐deoxychorismate Synthase PabB. Angewandte Chemie International Edition. 46(43). 8284–8286. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026